Menu

Nicolaas Schipper

Head of manufacture

Tel

+46 70 217 78 20

Email

nicolaas.schipper@ri.se

Location

Södertälje

ORCID

0000-0003-3401-0728

Nicolaas (Co) is responsible for the Pharmaceutical development test bed within RISE. His expertise is in pharmaceutical development from early preclinic to marketed drug formulations and life cycle management. He is head of the GMP production facilities in Södertälje. He has a PhD in pharmaceutics and (co) authored numerous articles and patents within the field of drug formulation, drug delivery, and drug absorption.

+ Show more

Ask me about

Publications

Ask me about

PHARMECO Advancing SSbD Practices in Pharmaceutical Manufacturing

PHARMECO aims to drive a green transition in the manufacture of medicine and reduce the environmental impact of (bio)pharmaceutical manufacturing routes.

PLATINEA: Platform for Innovation of Existing Antibiotics

PLATINEA is a multisectoral collaboration platform with the aim to preserve and enhance the value of existing antibiotics. PLATINEA consists of 23 partners from academia, authorities, industry and healthcare. The common goal is to…

How Sweden will improve its pharmaceutical preparedness

A delivery stoppage in Asia – and suddenly Sweden is facing a shortage of vital medicines. Global supply chains are more fragile than ever. The slightest disruption can quickly have consequences for healthcare. We now need to stre…

New substance offers hope for a cure against multi-resistant bacteria

The Swiss biotech company Juvabis is developing a new substance, EBL-1003, as part of the ENABLE project. The substance could be used to treat patients with illnesses caused by multi-resistant bacteria.

Pharmaceutical development – from idea to safe product

With a unique breadth, RISE offers offers help and support for pharmaceutical development – from idea to safe product.

New drug for hereditary eye diseases

Hereditary retinal disease is the most common cause of serious vision impairment among people of working age. There are currently around 5,000 people in Sweden with this type of disease and worldwide, approximately 1 out of every …

New drug could help with neurologic conditions

When a drug is going to be developed, not only does an active substance have to be developed - it must also be an effective drug preparation, so that the substance can be properly absorbed by the body. RISE is collaborating with t…

Drug formulation

Formulation development is an important part of the product development of new medicines. A well-designed formulation can have a crucial role for the drug candidate's success clinically. Our formulation scientists have good knowle…

Chemical manufacturing processes

Chemical processes, design and development from laboratory up to pilot scale. The challenges to create sustainable chemical processes are many! We have solutions providing green and sustainable manufacturing processes.

Formulation

What do skin lotions, paints, painkiller pills and mayonnaise have in common? Well, they are all formulated products. As such, their final properties and function are the result of the formulation work, this is, the process of sel…

Publications

See all DIVA publications